In charts | COVID-19 cases in India, state-wise trends, vaccination data, and other key details

India reported over 3 lakh COVID-19 new cases for the sixth straight day, according to the April 27 update. Active cases rose to 28.82 lakh mark. Over 14.52 crore vaccinations have been administered to date.

Moneycontrol News

April 27, 2021 / 11:13 AM IST

(Image: AP)

India’s COVID-19 case tally is now above 1.76 crores with 3,23,144 new cases reported, as per the health ministry’s April 27, 2021 update. New cases were above the 3 lakh mark for the sixth consecutive day; however, the lowest in five days.

India reported 2,771 new deaths and 2,51,827 new recoveries in the last 24 hours, the latest release shows. More than 14.52 crore vaccinations have been administered across India, according to the April 27 update, with 33,59,963 new vaccinations.

Of the total vaccinations administered to date, 84 percent received their first dose while 16 percent got the second dose. Among states, Maharashtra has administered the most over 14.9 million vaccine doses, followed by Rajasthan (12.5 million) and Uttar Pradesh (11.9 million).

India now has 28,82,204 active cases, with an increase of 68,546 cases in 24 hours as per the April 27 update. Maharashtra now has the most (6,76,647 or 23 percent) active cases in the country, followed by Uttar Pradesh (3,04,199) and Karnataka (2,81,061). Maharashtra, Delhi and Chhattisgarh have reported a drop in active cases.

Maharashtra reported the most (48,700 or 15 percent) new cases in the last 24 hours, followed by Uttar Pradesh (33,551), Karnataka (29,744), Kerala (21,890) and Delhi (20,201). These five states account for 48 percent of all the new cases reported in India.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show